表 1.
Characteristics | ICGF-based group (n=100) | MID group (n=98) | P |
SD: standard deviation; FEV1: forced expiratory volume in one second; COPD: chronic obstructive pulmonary disease; AAH: atypical adenomatous hyperplasia; AIS: adenocarcinoma in situ; MIA: minimally invasive adenocarcinoma; IAC: invasive adenocarcinoma. | |||
Age (Mean±SD, yr) | 59.8±10.5 | 60.6±7.9 | 0.500 |
Gender [n (%)] | 0.242 | ||
Male | 43 (43.0%) | 48 (49.0%) | |
Female | 57 (57.0%) | 50 (51.0%) | |
Smoking status [n (%)] | 0.402 | ||
Ever | 80 (80.0%) | 76 (77.6%) | |
Never | 20 (20.0%) | 22 (22.4%) | |
FEV1 (Mean±SD, L) | 2.5±0.6 | 2.4±0.7 | 0.789 |
COPD [n (%)] | 0.391 | ||
Yes | 10 (10.0%) | 12 (12.2%) | |
No | 90 (90.0%) | 86 (87.8%) | |
Tumor size (Mean±SD, mm) | 11.6±3.9 | 11.6±3.7 | 0.893 |
Pleural adhesions [n (%)] | 0.439 | ||
Yes | 86 (86.0%) | 12 (12.2%) | |
No | 14 (14.0%) | 86 (87.8%) | |
Pathological diagnosis [n (%)] | 0.579 | ||
AAH | 4 (4.0%) | 1 (1.0%) | |
AIS | 34 (34.0%) | 37 (37.8%) | |
MIA | 52 (52.0%) | 51 (52.0%) | |
IAC | 10 (10.0%) | 9 (9.2%) |